July 15, 2019: FemPulse Announces Enrollment of First Patient in Clinical Study for Personalized Treatment of Overactive Bladder (OAB) in Women
FemPulse Corporation announced the first participant has been enrolled in the Company’s clinical trial evaluating physiological responses to therapy delivered with the FemPulse System. Observations from this feasibility study can further help elucidate the mechanisms of action and facilitate tailoring treatment plans for individual patients. Read the Rest of the Article
